Researchers reported a novel blood-based biomarker panel for early diagnosis, monitoring of therapeutic response, and prognostic evaluation of patients with NSCLC brain metastasis.
[British Journal of Cancer]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
172440
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
